Matthew C Riddle (Matthew Riddle)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Venues

Diabetes care

Diabetes, obesity & metabolism

Diabetic medicine : a journal of the British Diabetic Association

Annals of internal medicine

Oregon Health and Science University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oregon Health and Science University Sep 01 1973

United States

Professor :: Endocrinology, Diabetes, & Clinical Nutrition

Publications

Matthew C Riddle
Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes care 47 (4) (2024)
Matthew C Riddle
Individualizing Treatment of Type 2 Diabetes After Metformin: More Insights From GRADE. Diabetes care 47 (4) (2024)
Grit Andersen, Rosy Eloy, Tim Heise, Martin Gaudier, Claire Mégret, Cyril Seroussi, You-Ping Chan, Olivier Soula, Matthew C Riddle, J Hans DeVries
ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes. Diabetes, obesity & metabolism (2024)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Steven E Kahn, Cheryl A M Anderson, Mark A Atkinson, George L Bakris, John B Buse, Frank B Hu, Stephen S Rich, Matthew C Riddle, Elizabeth Selvin
Reducing Bias in Academic Publishing: The Diabetes Care Approach. Diabetes care 46 (4) (2023)
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You-Ping Chan, Olivier Soula, Matthew C Riddle
A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Grit Andersen, Rosy Eloy, Susanne Famulla, Tim Heise, Grégory Meiffren, Cyril Seroussi, Martin Gaudier, Claire Mégret, You-Ping Chan, Olivier Soula, Matthew C Riddle
A co-formulation of pramlintide and insulin A21G (ADO09) improves post-prandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism 25 (4) (2023)
Matthew C Riddle
Here's to 100 Years of Insulin and Science-and More to Come! Diabetes care 45 (1) (2022)
Matthew C Riddle, null null, George L Bakris, Lawrence Blonde, Andrew J M Boulton, Jessica R Castle, Linda A DiMeglio, Linda Gonder-Frederick, Frank B Hu, Steven E Kahn, Sanjay Kaul, Robert Geoffrey Moses, Stephen S Rich, Julio Rosenstock, Elizabeth Selvin, Adrian Vella, Judith Wylie-Rosett
Editorial Cycles and Continuity of Diabetes Care. Diabetes care 45 (7) (2022)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial. Diabetes, obesity & metabolism (2022)
Edward Franek, Ulagamadesan Venkatesan, Matthew C Riddle, Claudia Nicolay, Ana Hickey, Fady T Botros, Li Shen Loo
Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial. Diabetes, obesity & metabolism 24 (9) (2022)
Ulagamadesan Venkatesan, Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Sibylle Hess, Lars Kober, Aldo P Maggioni, John J V McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Effect of Lixisenatide on Natriuretic Peptides in People With Type 2 Diabetes And Recent Acute Coronary Syndrome: The ELIXA Trial. Diabetes, obesity & metabolism (2022)
Ulagamadesan Venkatesan, Sibylle Hess, Brian Claggett, Kenneth Dickstein, Lars Kober, Aldo P Maggioni, John Joseph Valentine McMurray, Jeffrey L Probstfield, Matthew C Riddle, Jean-Claude Tardif, Marc A Pfeffer
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study. Diabetes care 45 (9) (2022)
Michael Szarek, Deepak L Bhatt, Ph Gabriel Steg, Christopher P Cannon, Lawrence Alan Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra, Lars H Lund, Michel Komajda, Jeffrey M Testani, Christopher S Wilcox, Piotr Ponikowski, Renato Deláscio Lopes, Phillip Banks, Eshetu Tesfaye, Justin A Ezekowitz, Subodh Verma, Bertram Pitt, null null
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial. Annals of internal medicine 174 (8) (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 64 (11) (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes care (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour
Consensus report: Definition and interpretation of remission in type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association (2021)
Matthew C Riddle, William T Cefalu, Philip H Evans, Ulagamadesan Venkatesan, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip R Schauer, Roy Taylor, Douglas Twenefour
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism (2021)
Matthew C Riddle
Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters. Diabetes care (2021)
Matthew C Riddle, Louis H Philipson, Stephen S Rich, Annelie Carlsson, Paul W Franks, Siri Atma W Greeley, John J Nolan, Ewan R Pearson, Philip S Zeitler, Andrew T Hattersley
Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum. Diabetes care 43 (12) (2021)
Matthew C Riddle, William T Cefalu, Edward W Gregg
Response to Comment on Riddle et al. Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes Care 2019;42:1136-1146. Diabetes care 42 (11) (2020)
Matthew C Riddle
Rediscovery of the Second β-Cell Hormone: Co-replacement With Pramlintide and Insulin in Type 1 Diabetes. Diabetes care 43 (3) (2020)
Frank Qian, Matthew C Riddle, Judith Wylie-Rosett, Frank B Hu
Red and Processed Meats and Health Risks: How Strong Is the Evidence? Diabetes care 43 (2) (2020)
Matthew C Riddle, Lawrence Blonde, Ulagamadesan Venkatesan, Edward W Gregg, Rury R Holman, John M Lachin, Gregory A Nichols, Alexander Turchin, William T Cefalu
Diabetes Care Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care. Diabetes care 42 (6) (2020)
Matthew C Riddle
A Verdict for Glimepiride: Effective and Not Guilty of Cardiovascular Harm. Diabetes care 42 (12) (2020)
Matthew C Riddle, John B Buse, Paul W Franks, William C Knowler, Robert E Ratner, Elizabeth Selvin, Deborah J Wexler, Steven E Kahn
COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports. Diabetes care 43 (7) (2020)
Matthew C Riddle
Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis. Diabetes care 43 (10) (2020)
Matthew C Riddle, William T Cefalu
SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True? Diabetes care 41 (12) (2019)
Matthew C Riddle, Ulagamadesan Venkatesan
The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study. Diabetes care 42 (7) (2019)
Kristina S Boye, Matthew C Riddle, Ulagamadesan Venkatesan, Reema Mody, Luis-Emilio Garcia-Perez, Chrisanthi A Karanikas, Maureen J Lage, Jeffrey S Riesmeyer, Mark C Lakshmanan
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States. Diabetes, obesity & metabolism 21 (6) (2019)
John B Buse, David A D'Alessio, Matthew C Riddle
Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes? Diabetes care 41 (8) (2018)
Yasuo Terauchi, Matthew C Riddle, Takahisa Hirose, Masayoshi Koyama, Xi Cheng, Yoshinori Takahashi, Geremia B Bolli
Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12-month comparison by concomitant sulphonylurea and/or glinide use. Diabetes, obesity & metabolism 20 (11) (2018)
Geremia B Bolli, Carol Wysham, Miles Fisher, Soazig Chevalier, Anna M G Cali, Bruno Leroy, Matthew C Riddle
A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimen. Diabetes, obesity & metabolism 21 (2) (2018)
Matthew C Riddle, Rajaa Nahra, Jenny Han, Jessica R Castle, Kathryn Hanavan, Marcus Hompesch, David Huffman, Poul Strange, Peter Öhman
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study. Diabetes care 41 (11) (2018)
Ulagamadesan Venkatesan, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Matthew C Riddle, Lars Rydén, Denis Xavier, Charles M Atisso, Alvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C Cushman, Edward Franek, Nicolae Hancu, Markolf Hanefeld, Shaun Holt, Petr Jansky, Matyas Keltai, Fernando Lanas, Lawrence Alan Leiter, Patricio Lopez-Jaramillo, Ernesto G Cardona-Munoz, Valdis Pirags, Nana Pogosova, Peter J Raubenheimer, Jonathan Edward Shaw, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev, null null
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Diabetes, obesity & metabolism 20 (1) (2017)
Philip D Home, Richard M Bergenstal, Geremia B Bolli, Monika Ziemen, Maria Rojeski, Melanie Espinasse, Matthew C Riddle
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes (EDITION 4). Diabetes, obesity & metabolism 20 (1) (2017)
Ulagamadesan Venkatesan, Eleuterio Ferrannini, Matthew C Riddle, Salim Yusuf, null null
Insulin resistance and cardiovascular outcomes in the ORIGIN trial. Diabetes, obesity & metabolism 20 (3) (2017)

Matthew C Riddle (Matthew Riddle)

Publication Activity (10 Years)

Top Topics

Top Venues